FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
MGOYX
Price
$14.62
Change
+$0.07 (+0.48%)
Updated
Aug 21 closing price
Net Assets
316.45M
Interact to see
Advertisement

FSMAX vs MGOYX

FSMAX vs MGOYX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. MGOYX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and MGOYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. MGOYX (316M). FSMAX pays higher dividends than MGOYX: FSMAX (0.50) vs MGOYX (0.03). FSMAX was incepted earlier than MGOYX: FSMAX (15 years) vs MGOYX (28 years). MGOYX (1.00) is less costly to investors than FSMAX (0.04). MGOYX is a more actively managed with annual turnover of: 89.00 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than MGOYX: FSMAX (0) vs MGOYX (1000000). FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. MGOYX (8.66). FSMAX return over 5 years is better than : 40.14 vs. MGOYX (-25.04).
FSMAXMGOYXFSMAX / MGOYX
Total Expense Ratio0.041.004%
Annual Report Gross Expense Ratio0.041.004%
Fund Existence15 years28 years-
Gain YTD16.93721.83378%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B316M12,690%
Annual Yield % from dividends0.500.031,878%
Returns for 1 year23.688.66274%
Returns for 3 years72.7419.20379%
Returns for 5 years40.14-25.04-160%
Returns for 10 years134.49-62.71-214%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIICX51.040.58
+1.15%
American Funds Intl Gr and Inc 529-C
FCUCX20.460.08
+0.39%
NYLI PineStone U.S. Equity Class C
ISCGX5.500.02
+0.36%
Transamerica Small Cap Growth I
HFDCX20.760.06
+0.29%
Hartford Schroders US MidCap Opps C
FHCCX43.67N/A
N/A
Fidelity Advisor Health Care C